Drugs Made In America Acquisition Corp. Ordinary Shares Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KARPUS MANAGEMENT, INC. | 11/14/2025 | 2.55 M | $26.16 M | -7.16% | 7.60% |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 11/17/2025 | 2.24 M | $23.03 M | 0.00% | 6.69% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 12/01/2025 | 1.90 M | $19.51 M | 0.00% | 5.67% |
| GLAZER CAPITAL, LLC | 11/13/2025 | 1.82 M | $18.72 M | -0.01% | 5.44% |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.67 M | $17.14 M | 0.00% | 4.98% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 12/15/2025 | 1.55 M | $15.92 M | -13.89% | 4.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 10/28/2025 | 1.25 M | $12.83 M | 22.24% | 3.73% |
| MIZUHO SECURITIES USA LLC | 10/22/2025 | 1.10 M | $11.29 M | 19.64% | 3.28% |
| ARISTEIA CAPITAL LLC | 11/14/2025 | 881.72 K | $9.06 M | 0.00% | 2.63% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 690.00 K | $7.09 M | 0.00% | 2.06% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 11/18/2025 | 650.00 K | $6.68 M | 0.00% | 1.94% |
| RADCLIFFE CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 528.10 K | $5.42 M | 316.74% | 1.58% |
| J. GOLDMAN & CO LP | 11/14/2025 | 500.00 K | $5.14 M | 100.00% | 1.49% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 500.00 K | $5.14 M | -12.28% | 1.49% |
| LMR PARTNERS LLP | 11/14/2025 | 500.00 K | $5.14 M | 0.00% | 1.49% |
| ATW SPAC MANAGEMENT LLC | 11/12/2025 | 500.00 K | $5.14 M | -12.28% | 1.49% |
| TORONTO DOMINION BANK | 11/14/2025 | 450.00 K | $4.62 M | -10.00% | 1.34% |
| WHITEBOX ADVISORS LLC | 11/14/2025 | 400.00 K | $4.11 M | 0.00% | 1.19% |
| AQR ARBITRAGE LLC | 11/14/2025 | 371.21 K | $3.81 M | -1.36% | 1.11% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 11/14/2025 | 318.00 K | $3.27 M | 100.00% | 0.95% |
| CONTEXT CAPITAL MANAGEMENT, LLC | 11/12/2025 | 250.00 K | $2.57 M | 100.00% | 0.75% |
| CLEAR STREET GROUP INC. | 11/14/2025 | 209.57 K | $2.15 M | 100.00% | 0.63% |
| SHAOLIN CAPITAL MANAGEMENT LLC | 11/14/2025 | 150.00 K | $1.54 M | 50.00% | 0.45% |
| BULLDOG INVESTORS, LLP | 11/14/2025 | 130.26 K | $1.34 M | 78.53% | 0.39% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 119.69 K | $1.23 M | 0.00% | 0.36% |
| DLD ASSET MANAGEMENT, LP | 11/14/2025 | 113.67 K | $1.17 M | -39.77% | 0.34% |
| JPMORGAN CHASE & CO | 11/26/2025 | 99.69 K | $1.02 M | 100.00% | 0.30% |
| WARBERG ASSET MANAGEMENT LLC | 11/06/2025 | 92.06 K | $945.41 K | 0.00% | 0.27% |
| PERISCOPE CAPITAL INC. | 11/13/2025 | 50.00 K | $513.50 K | 100.00% | 0.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 45.65 K | $468.80 K | 0.00% | 0.14% |
| DAKOTA WEALTH MANAGEMENT | 11/10/2025 | 36.40 K | $373.83 K | 100.00% | 0.11% |
| HRT FINANCIAL LP | 11/14/2025 | 27.49 K | $282.00 K | 100.00% | 0.08% |
| UBS GROUP AG | 11/13/2025 | 20.12 K | $206.64 K | 2,012,000.00% | 0.06% |
| SANDIA INVESTMENT MANAGEMENT LP | 11/14/2025 | 15.72 K | $161.46 K | 100.00% | 0.05% |
| QUARRY LP | 11/14/2025 | 15.72 K | $161.46 K | 100.00% | 0.05% |
| GOVERNORS LANE LP | 11/14/2025 | 11.20 K | $115.02 K | 100.00% | 0.03% |
| MORGAN STANLEY | 11/14/2025 | 32 | $329 | -70.64% | 0.00% |
| VERITION FUND MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MANGROVE PARTNERS | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LOGAN STONE CAPITAL, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Drugs Made In America Acquisition Corp. Ordinary Shares institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Drugs Made In America Acquisition Corp. Ordinary Shares. The most heavily invested institutionals were:
Karpus Management, Inc.: 2.55 M
First Trust Capital Management L.P.: 2.24 M
Polar Asset Management Partners Inc.: 1.9 M
GLAZER CAPITAL, LLC: 1.82 M
Westchester Capital Management, LLC: 1.67 M
Hudson Bay Capital Management LP: 1.55 M
64.91% of Drugs Made In America Acquisition Corp. Ordinary Shares stock is owned by institutional investors.
Institutional investors have bought a total of 22.41 M shares in the last 24 months. This purchase volume represents approximately $232.20 M in transactions.